About Akshaya Bio

About company

Akshaya develops innovative therapeutics for infectious diseases and cancer. Akshaya's proprietary Chimigen® Platform Technology uses dendritic cell receptor-targeted chimeric molecules to develop a portfolio of biotherapeutic agents to meet major unmet medical needs such as treatments for chronic hepatitis B and hepatitis C virus infections, avian and swine influenza, alphavirus infections, malaria, HIV and cancer.